Imuracetam

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Diptanshu Das (talk | contribs) at 15:00, 18 June 2017 (Category:Abandoned drugs). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Imuracetam
Names
IUPAC name
N,N'-Bis[(2-oxopyrrolidin-1-yl)methyl]urea
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
UNII
  • InChI=1S/C11H18N4O3/c16-9-3-1-5-14(9)7-12-11(18)13-8-15-6-2-4-10(15)17/h1-8H2,(H2,12,13,18) checkY
    Key: WMKONRFEZGAHTE-UHFFFAOYSA-N checkY
  • InChI=1/C11H18N4O3/c16-9-3-1-5-14(9)7-12-11(18)13-8-15-6-2-4-10(15)17/h1-8H2,(H2,12,13,18)
    Key: WMKONRFEZGAHTE-UHFFFAOYAT
  • O=C(NCN1C(=O)CCC1)NCN2C(=O)CCC2
Properties
C11H18N4O3
Molar mass 254.290 g·mol−1
Melting point 184.5 °C (364.1 °F; 457.6 K)[1]
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
checkY verify (what is checkY☒N ?)

Imuracetam is a drug of the racetam family.[2] It was under development in the 1970s, but was never marketed.[1]

References

  1. ^ a b C.R. Ganellin; David J. Triggle (1996). Dictionary of Pharmacological Agents. Vol. 3. CRC Press.
  2. ^ Avetisyan SA, Kocharov SL, Azaryan LV, Dzhagatspanyan IA, Melikyan GG. Synthesis and psychotropic activity of new 2-pyrrolidone derivatives. Pharmaceutical Chemistry Journal. 1998; 32(2):55-58.